ストックスクリーナーアプリを入手
52.86
5.72%
2.86
アフターアワーズ：
53.20
0.34
+0.64%
前日終値:
$50.00
開ける：
$52.63
24時間の取引高:
81.41M
Relative Volume:
23.60
時価総額：
$5.75B
収益：
-
当期純損益:
$-94.44M
株価収益率:
-51.22
EPS:
-1.032
ネットキャッシュフロー:
$-77.99M
1週間 パフォーマンス:
+10.63%
1か月 パフォーマンス:
+27.74%
6か月 パフォーマンス:
+610.48%
1年 パフォーマンス:
+1,492%
1日の値動き範囲:
$52.59
$52.98
1週間の範囲:
$46.75
$52.98
52週間の値動き範囲:
$1.865
$52.98
Terns Pharmaceuticals Inc Stock (TERN) Company Profile
名前
Terns Pharmaceuticals Inc
セクター
電話
650-525-5535 EXT.101
住所
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Compare TERN vs VRTX, REGN, ALNY, ARGX, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
52.86 | 5.44B | 0 | -94.44M | -77.99M | -1.032 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-09 | 開始されました | Leerink Partners | Outperform |
| 2025-11-04 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2025-11-03 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2025-10-15 | 開始されました | Truist | Buy |
| 2025-09-17 | 開始されました | Barclays | Overweight |
| 2025-09-04 | 再開されました | H.C. Wainwright | Neutral |
| 2025-02-28 | 開始されました | William Blair | Mkt Perform |
| 2024-10-31 | 開始されました | Oppenheimer | Outperform |
| 2023-06-22 | 開始されました | Mizuho | Buy |
| 2023-06-07 | 開始されました | Jefferies | Buy |
| 2023-05-31 | 開始されました | ROTH MKM | Buy |
| 2023-05-08 | 開始されました | BMO Capital Markets | Outperform |
| 2023-02-14 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-02-07 | 開始されました | UBS | Buy |
| 2022-09-12 | 開始されました | H.C. Wainwright | Neutral |
| 2021-09-14 | 再開されました | Goldman | Buy |
| 2021-03-02 | 開始されました | Cowen | Outperform |
| 2021-03-02 | 開始されました | Goldman | Buy |
| 2021-03-02 | 開始されました | JP Morgan | Overweight |
すべてを表示
Terns Pharmaceuticals Inc (TERN) 最新ニュース
Pharma giant Merck to acquire Terns Pharmaceuticals for $6.7 billion - marketscreener.com
Merck to acquire Terns Pharmaceuticals ahead of Keytruda patent expiration - The San Joaquin Valley Sun
Merck’s $6.7B Terns Acquisition Positions It to Challenge a Blockbuster Novartis Cancer Drug - MedCity News
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Terns Pharmaceuticals, Inc. (NASDAQ: TERN) - PR Newswire
Merck to buy Terns (TERN) NASDAQ for $53 on 25 Mar 2026: earnings catalyst for TERN stock - Meyka
Merck (MRK) Stock Acquires Terns Pharma (TERN) for $6.7 Billion to Bolster Cancer Pipeline - MEXC
Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B (XLV:NYSEARCA) - Seeking Alpha
Merck to acquire Terns Pharmaceuticals in $6.7B deal - Crain's New York
U.S. stock movements | Terns Pharmaceuticals, a biotechnology company, surged over 5% following its acquisition by Merck & Co for $6.7 billion. - 富途牛牛
Merck's (MRK) Offer for Terns Pharmaceuticals Critiqued by Willi - GuruFocus
Terns Pharma (TERN) Downgraded by HC Wainwright & Co. with Lower Price Target | TERN Stock News - GuruFocus
Mizuho reiterates Terns Pharmaceuticals stock rating after Merck deal - Investing.com
Merck's $6.7 Billion Terns Pharmaceuticals Acquisition May Face Rival Interest: Analyst - Benzinga
Merck's $6.7 Billion Terns Pharmaceuticals Acquisition May Face Rival Interest: Analyst - Benzinga
Terns Pharmaceuticals stock rating cut to neutral by H.C. Wainwright on Merck deal - Investing.com UK
MSD spends $6.7bn to buy Terns Pharmaceuticals in cancer pipeline reinforcement - Pharmaceutical Technology
Terns Pharmaceuticals jumps after Merck agrees to acquire it for $53 per share in cash - Quiver Quantitative
Merck bids $6.7 billion for Terns Pharmaceuticals - The Pharma Letter
Merck (MRK) Moves Forward with $6.7B Terns Pharmaceuticals Acqui - GuruFocus
Merck & Co., Inc. (MRK) Terns Pharmaceuticals, Inc.M&A CallSlideshow (NYSE:MRK) 2026-03-25 - Seeking Alpha
Merck buys Terns Pharmaceuticals for $6.7 billion to gain access to promising leukemia drug - ROI-NJ
Merck agrees to buy cancer drugmaker Terns for $53 per share - MLex
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science - Pharmaceutical Executive
Unsurging Financial Prospects for Terns Pharmaceuticals Inc. - timothysykes.com
Freshfields and Covington advise as Merck acquires US biotech company Terns for $6.7bn - Legal Business
Shareholder Alert: The Ademi Firm investigates whether Terns Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders - PR Newswire
Merck buying Terns in $6.7B deal to bolster its cancer portfolio before key Keytruda patent expires - WRAL
MRK: Acquisition brings TERN-701, a high-potential CML therapy, into the hematology portfolio - TradingView
Merck to Buy Terns Pharmaceuticals for $6.7 Billion to Boost Cancer Pipeline as Keytruda Patent Expiry Nears - TechStock²
Merck To Acquire Terns In $6.7B Deal – Signaling Fresh Push In Competitive Cancer Drug Race - Stocktwits
Merck nears $6 billion deal to buy Terns Pharma: Report - MSN
Merck to Acquire HBM Portfolio Company Terns Pharmaceuticals for USD 6.7 Billion - marketscreener.com
Merck acquires Terns Pharmaceuticals stock for $6.7 billion By Investing.com - Investing.com Australia
Merck To Buy Terns, ‘Unprecedented’ Leukemia Drug for $6.7B as Keytruda Cliff Looms - BioSpace
Merck Reaches Nearly $6 Billion Deal for Cancer Biotech Terns - WSJ
Merck makes bold $5.7 billion bet on Terns Pharmaceuticals - Rolling Out
Why Merck's $6.7 Billion Deal Could Start A Fight - Investor's Business Daily
Merck acquires Terns Pharmaceuticals stock for $6.7 billion - Investing.com
Merck close to $6B acquisition of Terns Pharma to boost cancer portfolio: FT - MSN
Merck to acquire Terns Pharmaceuticals in US$6.7 bil deal - The Edge Singapore
Merck to buy Terns Pharmaceuticals for $6.7bn - Sharecast.com
Merck (MRK.US) Plans to Acquire Biotech Firm Terns Pharmaceuticals (TERN.US) for USD6.7 Billion - AASTOCKS.com
MSD buys biotech Terns Pharmaceuticals for nearly USD 6bn - medwatch.com
Merck to Acquire Terns Pharmaceuticals in $6.7 Billion Deal - marketscreener.com
Merck (MRK) to Acquire Terns Pharmaceuticals for $6.7 Billion - GuruFocus
According to the latest disclosure documents from the SEC, the collaboration agreement between biopharmaceutical company Terns Pharmaceuticals and Merck includes a special clause: if the transaction is forced to terminate under certain circumstances, Te - Bitget
Merck (MRK) to Acquire Terns Pharmaceuticals (TERN) for $6.7 Bil - GuruFocus
TERN Stock Alert: Halper Sadeh LLC is Investigating Whether Terns Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders - The Joplin Globe
Terns Pharmaceuticals to Be Acquired by Merck - TipRanks
Merck to buy Terns Pharmaceuticals in $6.7B deal - statnews.com
Merck Seals $6.7B Deal to Acquire Terns Pharmaceuticals and Boosts Oncology Pipeline - StockInvest.us
Terns Pharmaceuticals Inc (TERN) 財務データ
収益
当期純利益
現金流量
EPS
1.82%
大文字化:
|
ボリューム (24 時間):